Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Other 1

Conditions

Neoplasms 10Lung Neoplasms 9Colorectal Neoplasms 7Breast Neoplasms 7Prostatic Neoplasms 6Rectal Neoplasms 3Polycystic Ovary Syndrome 3Neoplasm Metastasis 3Colonic Neoplasms 3Stomach Neoplasms 2Smoking Cessation 2Neoplastic Cells, Circulating 2Motor Activity 2Lymphoma 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia 2Endometrial Neoplasms 2Disease 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Venous Thromboembolism 1Vaginal Neoplasms 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1Testicular Germ Cell Tumor 1Stroke 1Solitary Pulmonary Nodule 1Skin Neoplasms 1Sezary Syndrome 1

Interventions

Echocardiography 14Doxorubicin 10Exercise 8Electrocardiography 7Trastuzumab 6Cyclophosphamide 5Carvedilol 5Docetaxel 3Atorvastatin 3salicylhydroxamic acid 2sacubitril and valsartan sodium hydrate drug combination 2empagliflozin 2dapagliflozin 2Tablets 2Social Determinants of Health 2Silymarin 2Magnetic Resonance Spectroscopy 2Ivabradine 2High-Intensity Interval Training 2Exercise Test 2Chemoradiotherapy 2Blood Specimen Collection 2Bisoprolol 2Antineoplastic Agents 2Anthracyclines 2sulforaphane 1schizandrin 1pegfilgrastim 1nicotinamide-beta-riboside 1mitoquinone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cardiotoxicity × Hematologic Tests × Clear all
NCT04827563 2026-03-04

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

University of Chicago

Terminated
50 enrolled
OtherPlasma cell

Dyspnea, Multiple Myeloma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡